Index RUT
P/E -
EPS (ttm) -3.26
Insider Own 14.30%
Shs Outstand 109.56M
Perf Week 13.53%
Market Cap 2.68B
Forward P/E -
EPS next Y -3.39
Insider Trans -1.24%
Shs Float 93.90M
Perf Month 20.39%
Income -331.34M
PEG -
EPS next Q -0.91
Inst Own 97.09%
Short Float / Ratio 17.30% / 6.55
Perf Quarter -30.10%
Sales 26.17M
P/S 102.57
EPS this Y -14.68%
Inst Trans 7.86%
Short Interest 16.25M
Perf Half Y -4.18%
Book/sh 7.65
P/B 3.20
EPS next Y 4.13%
ROA -36.61%
Target Price 33.62
Perf Year 3.86%
Cash/sh 7.42
P/C 3.30
EPS next 5Y -
ROE -43.63%
52W Range 15.44 - 35.60
Perf YTD 2.85%
Dividend -
P/FCF -
EPS past 5Y -39.15%
ROI -37.04%
52W High -31.18%
Beta 1.50
Dividend % -
Quick Ratio 9.64
Sales past 5Y 24.56%
Gross Margin 65.42%
52W Low 58.68%
ATR 1.44
Employees 246
Current Ratio 9.64
Sales Q/Q -100.00%
Oper. Margin -1409.77%
RSI (14) 60.70
Volatility 4.55% 5.59%
Optionable Yes
Debt/Eq 0.08
EPS Q/Q -14.66%
Profit Margin -1266.19%
Rel Volume 0.61
Prev Close 23.33
Shortable Yes
LT Debt/Eq 0.07
Earnings Nov 06 AMC
Payout -
Avg Volume 2.48M
Price 24.50
Recom 1.33
SMA20 14.81%
SMA50 2.37%
SMA200 -4.39%
Volume 1,505,692
Change 5.02%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-16-23 Initiated
Raymond James
Outperform
$30
Feb-28-23 Upgrade
JP Morgan
Neutral → Overweight
$32 → $38
Dec-14-22 Initiated
Needham
Buy
$31
Oct-21-22 Initiated
Oppenheimer
Outperform
$30
May-20-22 Initiated
BofA Securities
Neutral
$24
Mar-01-22 Upgrade
Stifel
Hold → Buy
$36 → $26
Sep-23-21 Initiated
Stifel
Hold
$34
Aug-12-21 Downgrade
Goldman
Buy → Neutral
$49 → $27
May-18-21 Initiated
Goldman
Buy
$49
May-21-20 Initiated
H.C. Wainwright
Buy
$55
Mar-09-20 Initiated
JP Morgan
Neutral
$32
Mar-09-20 Initiated
Guggenheim
Buy
$50
Mar-09-20 Initiated
Cowen
Outperform
Show Previous Ratings
Nov-09-23 09:10AM
Nov-08-23 11:30AM
Nov-07-23 10:14AM
Nov-06-23 05:50PM
04:55PM
04:05PM
Loading…
04:05PM
Nov-01-23 07:00AM
Oct-31-23 04:15PM
Oct-23-23 04:06PM
(Investor's Business Daily) -34.38%
01:48PM
12:04PM
10:07AM
(Investor's Business Daily)
Oct-22-23 02:30AM
Oct-19-23 07:02AM
Oct-16-23 03:19PM
(Investor's Business Daily) +14.08%
09:45AM
Loading…
09:45AM
Oct-13-23 02:54PM
11:50AM
Oct-04-23 04:05PM
Sep-20-23 07:01AM
Sep-19-23 07:00AM
Aug-17-23 04:05PM
Aug-09-23 02:13PM
Aug-08-23 05:50PM
04:05PM
Aug-03-23 04:05PM
Aug-01-23 02:34PM
(American City Business Journals) +20.00%
07:00AM
Jul-06-23 09:59AM
Jun-09-23 08:29AM
04:05PM
Loading…
Jun-08-23 04:05PM
May-24-23 04:05PM
May-13-23 08:19AM
May-10-23 06:10AM
May-09-23 09:40AM
(Thomson Reuters StreetEvents)
May-08-23 05:25PM
04:02PM
May-03-23 10:00AM
09:55AM
May-01-23 04:05PM
10:01AM
Apr-19-23 07:15AM
Apr-13-23 04:05PM
Apr-06-23 07:00AM
Mar-22-23 11:29AM
Mar-11-23 03:27AM
Mar-07-23 04:02PM
Mar-02-23 09:15PM
Mar-01-23 04:17PM
Feb-27-23 06:25PM
04:05PM
Feb-21-23 04:05PM
Feb-02-23 12:00PM
07:00AM
Jan-23-23 05:31AM
Jan-12-23 03:25AM
Jan-03-23 07:00AM
Dec-31-22 06:15AM
Dec-26-22 08:14AM
Dec-19-22 07:00AM
Dec-08-22 06:19AM
Dec-07-22 04:05PM
Nov-10-22 05:48AM
(Simply Wall St.) +13.34%
Nov-09-22 04:05PM
Nov-07-22 05:55PM
04:05PM
Nov-02-22 10:01AM
09:54AM
Nov-01-22 04:05PM
Oct-24-22 11:07AM
Oct-13-22 11:05AM
Sep-22-22 07:00AM
Sep-01-22 04:05PM
Aug-31-22 04:05PM
Aug-30-22 09:55AM
Aug-12-22 09:55AM
Aug-10-22 08:35AM
Aug-09-22 06:15PM
04:02PM
Jul-28-22 04:02PM
Jul-22-22 04:02PM
Jul-19-22 10:41PM
04:01PM
07:16AM
Jul-13-22 07:00AM
Jun-28-22 07:00AM
Jun-24-22 09:42AM
Jun-09-22 04:02PM
May-11-22 06:22AM
May-09-22 05:35PM
04:02PM
May-06-22 09:50AM
(Simply Wall St.) -16.26%
May-05-22 08:05PM
Apr-21-22 04:05PM
Apr-04-22 07:45AM
Mar-31-22 08:33AM
Mar-28-22 04:40PM
Mar-09-22 07:30AM
Mar-01-22 04:05PM
Feb-28-22 06:05PM
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cislini Jeff General Counsel Nov 20 Sale 21.70 1,500 32,545 38,513 Nov 20 06:24 PM Horn Margaret A Chief Operating Officer Oct 25 Option Exercise 0.54 7,500 4,050 104,460 Oct 25 06:20 PM GOLDSMITH MARK A See Remarks Oct 24 Option Exercise 0.49 35,000 17,150 384,332 Oct 24 07:21 PM Anders Jack Chief Financial Officer Oct 23 Option Exercise 2.98 24,524 72,967 78,191 Oct 23 06:01 PM Horn Margaret A Chief Operating Officer Oct 16 Option Exercise 4.09 25,000 102,250 121,960 Oct 18 04:23 PM Horn Margaret A Chief Operating Officer Oct 16 Sale 33.95 25,000 848,806 96,960 Oct 18 04:23 PM Kelsey Stephen Michael See Remarks Oct 11 Sale 29.05 16,667 484,130 273,721 Oct 13 04:20 PM Cislini Jeff General Counsel Sep 28 Sale 28.20 2,000 56,394 40,013 Oct 02 04:12 PM GOLDSMITH MARK A See Remarks Sep 18 Sale 31.31 8,054 252,175 349,332 Sep 20 04:12 PM Horn Margaret A Chief Operating Officer Sep 18 Sale 31.31 2,514 78,715 96,960 Sep 19 04:17 PM Kelsey Stephen Michael See Remarks Sep 18 Sale 31.31 2,060 64,500 290,388 Sep 20 04:13 PM Anders Jack Chief Financial Officer Sep 18 Sale 31.31 1,427 44,680 53,667 Sep 20 04:11 PM Cislini Jeff General Counsel Sep 18 Sale 31.31 1,214 38,011 42,013 Sep 20 04:11 PM Horn Margaret A Chief Operating Officer Sep 15 Option Exercise 4.09 5,000 20,450 104,474 Sep 19 04:17 PM Horn Margaret A Chief Operating Officer Sep 15 Sale 32.08 5,000 160,408 99,474 Sep 19 04:17 PM Weber Barbara Director Sep 01 Option Exercise 3.80 15,000 57,037 30,825 Sep 06 08:03 PM Anders Jack Chief Financial Officer Sep 01 Option Exercise 2.68 20,000 53,600 75,094 Sep 06 08:02 PM GOLDSMITH MARK A See Remarks Sep 01 Option Exercise 0.77 30,000 23,164 387,386 Sep 06 08:05 PM GOLDSMITH MARK A See Remarks Sep 01 Sale 35.05 30,000 1,051,563 357,386 Sep 06 08:05 PM Anders Jack Chief Financial Officer Sep 01 Sale 35.05 20,000 701,092 55,094 Sep 06 08:02 PM Weber Barbara Director Sep 01 Sale 35.07 15,000 526,000 15,825 Sep 06 08:03 PM GOLDSMITH MARK A See Remarks Sep 01 Sale 35.04 10,000 350,410 35,424 Sep 06 08:05 PM Horn Margaret A Chief Operating Officer Aug 31 Option Exercise 4.09 10,000 40,900 109,474 Sep 01 04:16 PM Horn Margaret A Chief Operating Officer Aug 31 Sale 34.05 10,000 340,458 99,474 Sep 01 04:16 PM Horn Margaret A Chief Operating Officer Aug 15 Option Exercise 4.09 5,000 20,450 104,474 Aug 17 04:17 PM Horn Margaret A Chief Operating Officer Aug 15 Sale 30.53 5,000 152,632 99,474 Aug 17 04:17 PM Kelsey Stephen Michael See Remarks Aug 02 Sale 32.40 16,666 539,978 292,448 Aug 03 04:17 PM Kelsey Stephen Michael See Remarks Aug 01 Sale 29.19 16,666 486,502 309,114 Aug 03 04:17 PM Cislini Jeff General Counsel Jul 31 Sale 26.02 1,500 39,030 43,227 Aug 01 06:23 PM Kelsey Stephen Michael See Remarks Jun 20 Sale 24.89 2,102 52,321 325,780 Jun 22 04:26 PM Horn Margaret A Chief Operating Officer Jun 20 Sale 24.89 2,102 52,321 99,474 Jun 22 04:26 PM Cislini Jeff General Counsel Jun 20 Sale 25.14 1,239 31,148 44,727 Jun 22 04:24 PM Anders Jack Chief Financial Officer Jun 20 Sale 24.89 1,249 31,089 55,094 Jun 22 04:25 PM Kelsey Stephen Michael See Remarks Mar 17 Sale 21.78 1,230 26,789 326,369 Mar 21 08:33 PM Horn Margaret A See Remarks Mar 17 Sale 21.78 1,230 26,789 100,062 Mar 21 08:33 PM Wang Xiaolin See Remarks Mar 17 Sale 21.78 714 15,551 58,813 Mar 21 08:32 PM Anders Jack Chief Financial Officer Mar 17 Sale 21.78 665 14,484 55,233 Mar 21 08:33 PM Schroeder Thilo Director Mar 10 Buy 20.46 100,000 2,045,604 1,553,134 Mar 10 07:00 PM Schroeder Thilo Director Mar 07 Buy 22.00 550,000 12,100,000 1,453,134 Mar 10 07:00 PM GOLDSMITH MARK A See Remarks Feb 22 Option Exercise 0.49 45,000 22,050 251,872 Feb 23 07:33 PM Kelsey Stephen Michael See Remarks Dec 19 Sale 22.94 1,220 27,986 287,599 Dec 21 04:06 PM Horn Margaret A See Remarks Dec 19 Sale 22.94 1,220 27,985 61,292 Dec 21 04:05 PM Wang Xiaolin See Remarks Dec 19 Sale 22.94 708 16,241 30,527 Dec 21 04:07 PM Anders Jack Chief Financial Officer Dec 19 Sale 22.94 658 15,095 29,298 Dec 21 04:08 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite